Neoantigen: A New Breakthrough in Tumor Immunotherapy

Neoantigen: A New Breakthrough in Tumor Immunotherapy

Cancer immunotherapy works by stimulating and strengthening the body’s anti-tumor immune response to eliminate cancer cells. Over the past few decades, immunotherapy has shown remarkable efficacy in the treatment of cancer, particularly the success of immune checkpoint blockade targeting CTLA-4, PD-...

Full description

Bibliographic Details
Main Authors:	Zheying Zhang, Manman Lu, Yu Qin, Wuji Gao, Li Tao, Wei Su, Jiateng Zhong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Immunology
Subjects:	immunotherapy neoantigen tumor-specific antigens vaccine personalized cancer immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.672356/full

Similar Items

The Role of Neoantigens in Cancer Immunotherapy
by: Yueting Zhu, et al.
Published: (2021-08-01)

Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
by: Yicheng Zhu, et al.
Published: (2021-06-01)

Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021-07-01)

The landscape of neoantigens and its clinical applications: From immunobiology to cancer vaccines
by: Chiranjib Chakraborty, et al.
Published: (2024-01-01)

Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
by: Thomas C. Wirth, et al.
Published: (2017-12-01)

Personalized Neoantigen-Pulsed DC Vaccines: Advances in Clinical Applications
by: Lin Tang, et al.
Published: (2021-07-01)

Mutation-Derived Neoantigens for Cancer Immunotherapy
by: John C. Castle, et al.
Published: (2019-08-01)

Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer
by: Yaojun Yu, et al.
Published: (2022-01-01)

The Value of Microbes in Cancer Neoantigen Immunotherapy
by: Junrui Tian, et al.
Published: (2023-08-01)

Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
by: Berta Segura-Collar, et al.
Published: (2023-05-01)

Computational cancer neoantigen prediction: current status and recent advances
by: G. Fotakis, et al.
Published: (2021-12-01)

Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
by: Lu Diao, et al.
Published: (2023-08-01)

Generation of Tumor-Specific Cytotoxic T Cells From Blood via In Vitro Expansion Using Autologous Dendritic Cells Pulsed With Neoantigen-Coupled Microbeads
by: Adela Kiessling, et al.
Published: (2022-03-01)

Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
by: Yanwei Shen, et al.
Published: (2022-08-01)

High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
by: Angela Mauriello, et al.
Published: (2019-11-01)

Cancer neoantigens and immunogenicity: mutation position matters
by: Aude-Hélène Capietto, et al.
Published: (2020-05-01)

A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
by: Zhe Jing, et al.
Published: (2022-08-01)

Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients
by: Annacarmen Petrizzo, et al.
Published: (2018-10-01)

Neoantigen-Reactive T Cells: The Driving Force behind Successful Melanoma Immunotherapy
by: Lindy Davis, et al.
Published: (2021-12-01)

The Identification and Clinical Applications of Mutated Antigens in the Era of Immunotherapy
by: Yae Kye, et al.
Published: (2022-08-01)

Recent advances in neoantigen vaccines for treating non‐small cell lung cancer
by: Shu Su, et al.
Published: (2023-12-01)

T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
by: Malcolm J. W. Sim, et al.
Published: (2022-02-01)

Spleen‐targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
by: Ming Wu, et al.
Published: (2023-10-01)

Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer
by: Kaïdre Bendjama, et al.
Published: (2017-09-01)

Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers
by: Shih-Cheng Pao, et al.
Published: (2022-04-01)

Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
by: Daniel J. Verdon, et al.
Published: (2021-08-01)

Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
by: Luigi Aurisicchio, et al.
Published: (2019-02-01)

ProGeo-Neo v2.0: A One-Stop Software for Neoantigen Prediction and Filtering Based on the Proteogenomics Strategy
by: Chunyu Liu, et al.
Published: (2022-04-01)

Lack of shared neoantigens in prevalent mutations in cancer
by: Concetta Ragone, et al.
Published: (2024-04-01)

Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy
by: Peipei Wang, et al.
Published: (2021-04-01)

Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment
by: Michael Fehlings, et al.
Published: (2019-09-01)

A Roadmap Toward the Definition of Actionable Tumor-Specific Antigens
by: Robin Minati, et al.
Published: (2020-12-01)

Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors
by: Yang Shi, et al.
Published: (2023-07-01)

Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy
by: Yu Cai, et al.
Published: (2023-01-01)

Development of neoantigens: from identification in cancer cells to application in cancer vaccines
by: Nasim Ebrahimi, et al.
Published: (2022-07-01)

Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies
by: Carson R. Reynolds, et al.
Published: (2022-01-01)

Clonal Neoantigen: Emerging “Mechanism-based” Biomarker of Immunotherapy Response
by: John Nemunaitis, et al.
Published: (2023-11-01)

Personal Neoantigens From Patients With NSCLC Induce Efficient Antitumor Responses
by: Wei Zhang, et al.
Published: (2021-04-01)

mRNA—From COVID-19 Treatment to Cancer Immunotherapy
by: Werner Krause
Published: (2023-01-01)

Neoantigens and their clinical applications in human gastrointestinal cancers
by: Zahra Shokati Eshkiki, et al.
Published: (2022-09-01)